![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1129, 2006-01, pp. : 19-19
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rituximab: Urticaria: case report
Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ondansetron: Urticaria: case report
Reactions Weekly, Vol. 1, Iss. 1046, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adalimumab: Urticaria: case report
Reactions Weekly, Vol. 1, Iss. 1169, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Montelukast: Urticaria: case report
Reactions Weekly, Vol. 1, Iss. 1211, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mebeverine: Urticaria: case report
Reactions Weekly, Vol. 1, Iss. 1393, 2012-01 ,pp. :